You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 38 Issue 9

November 2013

Volume 38, Issue 9

Pages 995–1144

  1. META-ANALYSIS

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis (pages 995–1001)

      M. Yaghoobi, S. Rolland, K. A. Waschke, J. McNabb-Baltar, M. Martel, R. Bijarchi, P. Szego and A. N. Barkun

      Version of Record online: 16 SEP 2013 | DOI: 10.1111/apt.12488

  2. REVIEW ARTICLES

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease (pages 1002–1024)

      G. W. Moran, A. W. K. Lim, J. L. Bailey, M.-F. Dubeau, Y. Leung, S. M. Devlin, K. Novak, G. G. Kaplan, M. Iacucci, C. Seow, L. Martin, R. Panaccione and S. Ghosh

      Version of Record online: 25 SEP 2013 | DOI: 10.1111/apt.12491

    2. You have free access to this content
    3. You have free access to this content
  3. RANDOMISED CLINICAL TRIALS

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Randomised clinical trial: MRCP-first vs. ERCP-first approach in patients with suspected biliary obstruction due to bile duct stones (pages 1045–1053)

      M. Bhat, J. Romagnuolo, E. da Silveira, C. Reinhold, E. Valois, M. Martel, J. S. Barkun and A. N. Barkun

      Version of Record online: 11 SEP 2013 | DOI: 10.1111/apt.12481

    2. You have free access to this content
  4. HEPATITIS C VIRUS

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study (pages 1076–1085)

      E. Ogawa, N. Furusyo, M. Nakamuta, E. Kajiwara, H. Nomura, K. Dohmen, K. Takahashi, T. Satoh, K. Azuma, A. Kawano, Y. Tanabe, K. Kotoh, S. Shimoda, J. Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

      Version of Record online: 17 SEP 2013 | DOI: 10.1111/apt.12494

  5. PORTAL HYPERTENSION

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have full text access to this OnlineOpen article
      Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension (pages 1086–1096)

      D. J. Leeming, M. A. Karsdal, I. Byrjalsen, F. Bendtsen, J. Trebicka, M. J. Nielsen, C. Christiansen, S. Møller and A. Krag

      Version of Record online: 15 SEP 2013 | DOI: 10.1111/apt.12484

  6. THIOPURINE NON-ADHERENCE AND IBD

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease (pages 1097–1108)

      J. R. Goodhand, N. Kamperidis, B. Sirwan, L. Macken, N. Tshuma, Y. Koodun, F. A. Chowdhury, N. M. Croft, N. Direkze, L. Langmead, P. M. Irving, D. S. Rampton and J. O. Lindsay

      Version of Record online: 15 SEP 2013 | DOI: 10.1111/apt.12476

  7. IRON DEFICIENCY ANAEMIA AND IBD

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have full text access to this OnlineOpen article
      The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method (pages 1109–1118)

      W. Reinisch, Y. Chowers, S. Danese, A. Dignass, F. Gomollón, O. Haagen Nielsen, P. L. Lakatos, C. W. Lees, S. Lindgren, M. Lukas, G. J. Mantzaris, P. Michetti, B. Moum, L. Peyrin-Biroulet, M. Toruner, J. van der Woude, G. Weiss and H. Stoevelaar

      Version of Record online: 17 SEP 2013 | DOI: 10.1111/apt.12493

  8. CLOPIDOGREL AND GI BLEEDING

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
  9. PROTON PUMP INHIBITORS AND ACID SECRETION

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
      Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole (pages 1129–1137)

      S. Sahara, M. Sugimoto, T. Uotani, H. Ichikawa, M. Yamade, M. Iwaizumi, T. Yamada, S. Osawa, K. Sugimoto, K. Umemura, H. Miyajima and T. Furuta

      Version of Record online: 16 SEP 2013 | DOI: 10.1111/apt.12492

  10. INVITED COMMENTARIES

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
  11. LETTERS TO THE EDITORS

    1. Top of page
    2. META-ANALYSIS
    3. REVIEW ARTICLES
    4. RANDOMISED CLINICAL TRIALS
    5. HEPATITIS C VIRUS
    6. PORTAL HYPERTENSION
    7. THIOPURINE NON-ADHERENCE AND IBD
    8. IRON DEFICIENCY ANAEMIA AND IBD
    9. CLOPIDOGREL AND GI BLEEDING
    10. PROTON PUMP INHIBITORS AND ACID SECRETION
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content

SEARCH

SEARCH BY CITATION